BMAL1 and Parkinson disease: Neurologically, nobiletin attenuates neurodegeneration in a Parkinson’s disease rat model by enhancing Bmal1 and activating the Bmal1/NRF2 axis, reducing ferroptosis and oxidative stress, and promoting mitophagy/autophagy [81].